Vigil Neuroscience Q1 2025 Update
| Field | Detail |
|---|---|
| Company | Vigil Neuroscience, Inc. |
| Form Type | 10-Q |
| Filed Date | May 7, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, biotechnology, R&D, financials
TL;DR
Vigil Neuro Q1 2025: R&D spending continues, equity plans active. #biotech
AI Summary
Vigil Neuroscience, Inc. filed its quarterly report for the period ending March 31, 2025. The company's primary focus remains on its research and development activities, with significant expenses in this area. The filing details various financial instruments and equity plans, including the 'TwoThousandTwentyEquityIncentivePlan'.
Why It Matters
This filing provides insight into Vigil Neuroscience's financial health and ongoing R&D efforts, crucial for investors tracking the company's progress in the biotechnology sector.
Risk Assessment
Risk Level: medium — Biotechnology companies often carry higher risk due to the inherent uncertainties in drug development and regulatory approvals.
Key Numbers
- 20250331 — Reporting Period End Date (Indicates the end of the fiscal quarter for this filing.)
- 20250507 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- Vigil Neuroscience, Inc. (company) — Filer of the 10-Q
- March 31, 2025 (date) — End of reporting period
- 20250331 (date) — Filing date for the period
- TwoThousandTwentyEquityIncentivePlan (plan) — Mentioned equity incentive plan
FAQ
What were the total research and development expenses for the quarter ending March 31, 2025?
The filing indicates 'ResearchAndDevelopmentExpenseMember' for the period January 1, 2024 to March 31, 2024, but specific dollar amounts for the 2025 period are not detailed in this excerpt.
What is the company's primary business focus?
The company is in the 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)' sector, with a focus on research and development.
When does Vigil Neuroscience's fiscal year end?
Vigil Neuroscience's fiscal year ends on December 31.
What is the company's state of incorporation?
Vigil Neuroscience, Inc. is incorporated in Delaware (DE).
What is the company's business address?
The business address is 100 Forge Road, Suite 700, Watertown, MA 02472.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 7, 2025 regarding Vigil Neuroscience, Inc..